Status:
COMPLETED
Using KomPas+ in the Treatment of Patients With Intermittent Claudication
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
Chronisch ZorgNet
Conditions:
Intermittent Claudication
Peripheral Arterial Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
Intermittent claudication is the most common symptom of peripheral arterial disease (PAD). The recommended therapy is supervised exercise therapy combined with lifestyle counselling, provided by a phy...
Eligibility Criteria
Inclusion
- Inclusion Criteria Primary objective:
- \- All therapists affiliated with Chronisch Zorgnet and specialized in the treatment of people with intermittent claudication are eligible to participate. Besides, all patients referred to a Chronisch Zorgnet therapist with intermittent claudication specialty are eligible to participate.
- Inclusion Criteria Secondary objective:
- Provides written informed consent (both therapist and patients)
- Therapists should have finished two KomPas (control group) or KomPas+ (experimental group) e-learnings
- Therapists should have applied KomPas (control group) or KomPas+ (experimental group) to at least one patient with intermittent claudication
- Inclusion Criteria Third objective:
- \- All therapists affiliated with Chronisch Zorgnet and specialized in the treatment of people with intermittent claudication who are included in the experimental group are eligible to participate.
- Exclusion Criteria:
- Not applicable due to the "real world" setting of the study.
Exclusion
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 4 2024
Estimated Enrollment :
2271 Patients enrolled
Trial Details
Trial ID
NCT05232474
Start Date
October 1 2022
End Date
June 4 2024
Last Update
December 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IQ healthcare, Radboudumc
Nijmegen, Netherlands, 6525 EP